Indaptus Therapeutics (INDP) Short Interest Ratio & Short Volume → [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad) Free INDP Stock Alerts $2.34 +0.03 (+1.30%) (As of 05/20/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Indaptus Therapeutics Short Interest DataCurrent Short Interest25,800 sharesPrevious Short Interest86,200 sharesChange Vs. Previous Month-70.07%Dollar Volume Sold Short$55,986.00Short Interest Ratio0.3 Days to CoverLast Record DateApril 30, 2024Outstanding Shares8,540,000 sharesFloat Size5,900,000 sharesShort Percent of Float0.44%Today's Trading Volume8,819 sharesAverage Trading Volume59,198 sharesToday's Volume Vs. Average15% Short Selling Indaptus Therapeutics ? Sign up to receive the latest short interest report for Indaptus Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartINDP Short Interest Over TimeINDP Days to Cover Over TimeINDP Percentage of Float Shorted Over Time Ad InvestorPlaceMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… Indaptus Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202425,800 shares $55,986.00 -70.1%0.4%0.3 $2.17 4/15/202486,200 shares $228,430.00 -13.9%1.5%1 $2.65 3/31/2024100,100 shares $224,224.00 +0.7%1.7%1.3 $2.24 3/15/202499,400 shares $185,878.00 +196.7%1.7%1.3 $1.87 2/29/202433,500 shares $73,700.00 +94.8%0.6%0.5 $2.20 2/15/202417,200 shares $29,928.00 +18.6%0.3%1.8 $1.74 Get the Latest News and Ratings for INDP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Indaptus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/202414,500 shares $23,925.00 -20.8%0.3%1.5 $1.65 1/15/202418,300 shares $33,855.00 -10.7%0.3%1.3 $1.85 12/31/202320,500 shares $36,080.00 -9.3%0.4%1.5 $1.76 12/15/202322,600 shares $44,748.00 -2.6%0.4%1.7 $1.98 11/30/202323,200 shares $52,432.00 +21.5%0.4%1.4 $2.26 11/15/202319,100 shares $42,020.00 +64.7%0.3%1 $2.20 10/31/202311,600 shares $26,448.00 -3.3%0.2%0.5 $2.28 10/15/202312,000 shares $30,720.00 -14.3%0.2%0.6 $2.56 9/30/202314,000 shares $38,570.00 -31.7%0.2%0.7 $2.76 9/15/202320,500 shares $69,290.00 -9.3%0.4%1 $3.38 8/31/202322,600 shares $64,862.00 -51.6%0.4%1.3 $2.87 8/15/202346,700 shares $104,608.00 +115.2%0.8%2.8 $2.24 7/31/202321,700 shares $44,919.00 +29.9%0.4%1.6 $2.07 7/15/202316,700 shares $31,730.00 -1.8%0.3%1.3 $1.90 6/30/202317,000 shares $32,470.00 -28.3%0.3%0.6 $1.91 6/15/202323,700 shares $46,452.00 -11.9%0.4%0.8 $1.96 5/31/202326,900 shares $43,847.00 -0.4%0.5%0.9 $1.63 5/15/202327,000 shares $56,160.00 -51.4%0.5%1 $2.08 4/30/202355,600 shares $145,060.40 +159.8%1.0%2 $2.61 4/15/202321,400 shares $41,730.00 -9.3%0.4%0.8 $1.95 3/31/202323,600 shares $43,660.00 -12.6%0.4%3.1 $1.85 3/15/202327,000 shares $41,040.00 +4.7%0.5%2.9 $1.52 2/28/202325,800 shares $45,150.00 -21.3%0.5%1 $1.75 2/15/202332,800 shares $58,712.00 -16.1%0.6%1.3 $1.79 1/31/202339,100 shares $69,207.00 +3.7%0.7%1.5 $1.77 1/15/202337,700 shares $61,451.00 -29.8%0.7%1.5 $1.63 12/30/202253,700 shares $77,865.00 -46.3%1.1%2.2 $1.45 12/15/2022100,000 shares $195,000.00 +498.8%2.0%4.2 $1.95 11/30/202216,700 shares $30,415.71 -4.6%0.3%1.6 $1.82 11/15/202217,500 shares $30,276.75 +5.4%0.4%1.6 $1.73 10/31/202216,600 shares $30,378.00 +9.2%0.3%1.4 $1.83 10/15/202215,200 shares $27,360.00 -14.6%0.3%1.1 $1.80 9/30/202217,800 shares $38,448.00 -21.9%0.4%1.1 $2.16 9/15/202222,800 shares $61,104.00 -8.1%0.5%0.9 $2.68Next President (Not Trump. Not Biden.) (Ad)Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.Click here to see why it will be ______ _________. 8/31/202224,800 shares $62,496.00 -31.7%0.5%0.7 $2.52 8/15/202236,300 shares $105,270.00 -36.9%0.7%0.6 $2.90 7/31/202257,500 shares $163,300.00 -25.3%1.1%0.1 $2.84 7/15/202277,000 shares $256,410.00 +49.8%1.5%0.2 $3.33 6/30/202251,400 shares $134,154.00 -42.6%1.0%0.1 $2.61 6/15/202289,500 shares $200,480.00 -50.9%1.6%0.2 $2.24 5/31/2022182,100 shares $460,713.00 +569.5%3.2%0.4 $2.53 5/15/202227,200 shares $67,456.00 -38.3%0.5%0.1 $2.48 4/30/202244,100 shares $129,213.00 -14.7%0.8%1 $2.93 4/15/202251,700 shares $177,331.00 -18.1%0.9%0.9 $3.43 3/31/202263,100 shares $252,400.00 -30.6%1.1%0.8 $4.00 3/15/202290,900 shares $289,971.00 +21.2%1.6%0.6 $3.19 2/28/202275,000 shares $313,500.00 +6.8%1.4%0.4 $4.18 2/15/202270,200 shares $351,000.00 -34.2%1.3%0.3 $5.00 1/31/2022106,600 shares $531,934.00 +2.8%1.9%0.4 $4.99 1/15/2022103,700 shares $547,536.00 +157.3%1.9%0.4 $5.28 12/31/202140,300 shares $229,710.00 No Change0.7%0.1 $5.70 INDP Short Interest - Frequently Asked Questions What is Indaptus Therapeutics' current short interest? Short interest is the volume of Indaptus Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 25,800 shares of INDP short. 0.44% of Indaptus Therapeutics' shares are currently sold short. Learn More on Indaptus Therapeutics' current short interest. What is a good short interest percentage for Indaptus Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.44% of Indaptus Therapeutics' floating shares are currently sold short. Is Indaptus Therapeutics' short interest increasing or decreasing? Indaptus Therapeutics saw a decline in short interest during the month of April. As of April 30th, there was short interest totaling 25,800 shares, a decline of 70.1% from the previous total of 86,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Indaptus Therapeutics' float size? Indaptus Therapeutics currently has issued a total of 8,540,000 shares. Some of Indaptus Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Indaptus Therapeutics currently has a public float of 5,900,000 shares. How does Indaptus Therapeutics' short interest compare to its competitors? 0.44% of Indaptus Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Indaptus Therapeutics: Sol-Gel Technologies Ltd. (0.04%), Aytu BioPharma, Inc. (7.15%), Galecto, Inc. (0.42%), Cocrystal Pharma, Inc. (0.11%), VBI Vaccines Inc. (1.38%), GlycoMimetics, Inc. (9.45%), KALA BIO, Inc. (0.36%), NeuroBo Pharmaceuticals, Inc. (2.06%), BioVie Inc. (3.18%), Minerva Neurosciences, Inc. (0.47%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Indaptus Therapeutics stock? Short selling INDP is an investing strategy that aims to generate trading profit from Indaptus Therapeutics as its price is falling. INDP shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Indaptus Therapeutics? A short squeeze for Indaptus Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of INDP, which in turn drives the price of the stock up even further. How often is Indaptus Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INDP, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: SLGL Short Interest Data AYTU Short Interest Data GLTO Short Interest Data COCP Short Interest Data VBIV Short Interest Data GLYC Short Interest Data KALA Short Interest Data NRBO Short Interest Data BIVI Short Interest Data NERV Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INDP) was last updated on 5/20/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsNext President (Not Trump. Not Biden.)The Freeport Society**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock Digest